-
Antiretroviral Drug Abacavir Found to Elevate CV Event Risk
07 Aug 2024 23:42 GMT
… Ziagen—according to a presentation at the 2024 International AIDS Conference (AIDS … the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE … (UC) College of Medicine who presented the results. … of a cholesterol-fighting statin drug reduced the risk …
-
Study Finds Abacavir Increases Cardiovascular Risk in Patients With HIV
08 Aug 2024 00:00 GMT
… found that abacavir (Ziagen; ViiV Healthcare) is … statin treatments in patients with HIV. The trial enrolled 7769 patients with HIV … -living-hiv
3. Exploratory analysis associates HIV drug abacavir … events in REPRIEVE trial. European AIDS Treatment Group. July …
-
Exploratory Analysis Associates HIV Drug Abacavir With Elevated Cardiovascular Disease Risk
24 Jul 2024 12:53 GMT
… at the 2024 International AIDS Conference (AIDS 2024) in Munich, … is sold alone as Ziagen and is a component of … combination pills.] The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE … of a cholesterol-fighting statin drug reduced the risk of …
-
New Gene Tests Can Predict if a Drug Will Work for a Patient
31 May 2024 11:41 GMT
… drugs including antidepressants, statins, pain killers, anticlotting medications for heart conditions, HIV treatments, chemotherapy agents, and antirejection drugs … and Pharmaceutical Sciences at … 108 drug labels currently tell doctors and patients …
-
Some Children Treated Very Early Have Sustained HIV Remission
07 Mar 2024 20:44 GMT
… of children who start HIV treatment within the first … Hopkins University School of Medicine, reported.
Deborah Persaud … end, researchers launched a trial called IMPAACT P1115 (NCT02140255 … AZT (Retrovir) or abacavir (Ziagen), lamivudine (Epivir) and nevirapine …
-
Some children who start antiretrovirals very early may control HIV after stopping treatment
07 Mar 2024 11:05 GMT
… daily medication.
Taking a planned break from HIV treatment, sometimes known as a ‘drugs … learn more, researchers launched a trial called IMPAACT P1115 (NCT02140255), funded … HIV during gestation. They initially received AZT (Retrovir) or abacavir (Ziagen …
-
Could Very Early Treatment Cure Babies Born With HIV?
13 Dec 2023 18:56 GMT
… Hopkins University School of Medicine reported the case … very early treatment. While ART can suppress HIV replication indefinitely … three-drug regimen of AZT (Retrovir) or abacavir (Ziagen), lamivudine … noted. As the trial continues, the researchers plan …
-
Netherlands Man in Remission 23 Years After Stopping HIV Treatment
22 Nov 2023 22:18 GMT
… stopping HIV treatment, according to a case report described in the journal AIDS … five-drug regimen consisting of stavudine (d4T), lamivudine (3TC), abacavir (Ziagen), the … ’ seven months after stopping treatment. However, plasma HIV RNA was detectable at …
-
HIV Type-1 Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Key Companies Developing Therapies - ViiV Healthcare, GlaxoSmithKline, PPD, Merck, Gilead, Janssen, AbbVie, Sanofi
02 Nov 2023 17:00 GMT
… Ireland UC, Vir Biotechnology, Inc., National Institute … (ARV) medications for HIV treatment are categorized into … FDA-approved drugs for HIV type-1 @ Drugs for HIV Type-1 Treatment Key HIV … HIV type-1 clinical trials, visit @ HIV Type-1 Treatment Drugs HIV …
-
Antiretroviral drugs: what Abacavir oral solution is and what it does
11 Jan 2023 11:10 GMT
… COMMON BRAND NAME(S): Ziagen, Ziagen Solution
What should I tell … of all the medicines, herbs, non-prescription drugs, or dietary … medicine, stop the medicine and call your doctor right away.
This medicine … : Kaposi’s Sarcoma
World AIDS Day: New Procedure To …